Search Result "plasminogen activator inhibitors (PAIs)"
Plasminogen Activator Inhibitor-1
Journal: Current Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2004 Page: 2323-2334
Author(s): Ann Gils, Paul J. Declerck
Plasminogen Activator Inhibitor with Very Long Half-life (VLHL PAI-1) can Reduce Bleeding in PAI-1-deficient Patients
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 13 Issue: 2 Year: 2013 Page: 144-150
Author(s): Jerzy Jankun, Ewa Skrzypczak-Jankun
Plasminogen Activator System and Vascular Disease
Journal: Current Vascular Pharmacology
Volume: 4 Issue: 2 Year: 2006 Page: 101-116
Author(s): Suzanne M. Nicholl, Elisa Roztocil, Mark G. Davies
Plasminogen Activator Inhibitor-1 in Tumor Growth, Angiogenesis and Vascular Remodeling
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 1 Year: 2003 Page: 1545-1564
Author(s): Steingrimur Stefansson, Grainne A. McMahon, Eric Petitclerc, Daniel A. Lawrence
Plasminogen Activator Inhibitor-1 and Restenosis
Journal: Current Drug Targets
Volume: 8 Issue: 9 Year: 2007 Page: 1003-1006
Author(s): Nadish Garg, William P. Fay
Plasminogen Activator Inhibitor-1 in Vascular Thrombosis
Journal: Current Drug Targets
Volume: 8 Issue: 9 Year: 2007 Page: 996-1002
Author(s): Randal J. Westrick, Daniel T. Eitzman
Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 1 Year: 2003 Page: 1483-1498
Author(s): Todd W. Rockway, Vincent L. Giranda
Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis
Journal: Current Drug Targets
Volume: 20 Issue: 16 Year: 2019 Page: 1695-1701
Author(s): Tetsumei Urano,Yuko Suzuki,Takayuki Iwaki,Hideto Sano,Naoki Honkura,Francis J. Castellino
The Urokinase Plasminogen Activator System: Role in Malignancy
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 39-49
Author(s): Michael J. Duffy
Effects of Altered Plasminogen Activator Inhibitor-1 Expression on Cardiovascular Disease
Journal: Current Drug Targets
Volume: 12 Issue: 1 Year: 2011 Page: 1782-1789
Author(s): Victoria A. Ploplis